BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 10, 2006
View Archived Issues
Mechanism of cystatin C and E-64 action on osteoclast differentiation elucidated
Read More
Phase IIb adrenomyeloneuropathy study of RPI-78M cleared to begin
Read More
Agreement for animal study of human fibroblast growth factor-1 in osteoporosis
Read More
Alkermes licenses novel opioid receptor compounds discovered at Rensselaer
Read More
Gabapentin GR study in diabetic peripheral neuropathy completes enrollment
Read More
Influenza protecting virus developed at U. of Warwick
Read More
Grant to study two new drug classes in HIV-related nerve damage
Read More
Targanta updates preclinical studies of their lead antibiotic candidate oritavancin
Read More
Brivaracetam to enter clinical trials as an add-on therapy for Unverricht-Lundborg disease
Read More
U.K. approval for phase III cystic fibrosis study of Bronchitol to begin
Read More
Genentech files IND for Hedgehog antagonist from Curis collaboration
Read More
Novo Nordisk reveals plans for new clinical trials into 2007
Read More
SPA completed for Genasense plus chemotherapy in CLL
Read More
FX-06 studied in new phase II trial for reperfusion injury
Read More
Approvable letter for NRP-104 in ADHD
Read More
Myodur IND for Duchenne muscular dystrophy remains on hold
Read More
Pharming receives orphan product grant for Rhucin
Read More
Symbicort SMART completes European mutual recognition procedure
Read More
Ceplene filed for European approval in AML
Read More
Recent patents report novel treatment strategies for respiratory disorders
Read More
Tykerb filed for European approval in advanced breast cancer
Read More
Remicade approved in E.U. for second-line therapy for Crohn's disease
Read More
Recent patents report new treatments for depression, psychosis, sleep disorders, etc.
Read More
HIV reverse transcriptase inhibitors emerge from Roche R&D
Read More
R&D highlights from the UBS Global Life Sciences Conference in New York: Metabolic Pharmaceuticals
Read More
Novel antmicrobial biomimetic compounds developed at PolyMedix show efficacy in vivo
Read More
Taisho's new ketolide shows promising in vitro and in vivo activity
Read More
Paratek and Merck & Co.'s MK-2764 preclinical activity profiled at the ICAAC meeting
Read More